RO-7297089

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameRO-7297089
Drug Alias NameRO-7297089AFM-26RG-6296
ClassificationBiologics
Mechanisms of ActionTumor necrosis factor ligand superfamily member 13 modulatorsImmunoglobulin epsilon Fc receptor antagonists
TargetsTumor necrosis factor ligand superfamily member 13Immunoglobulin epsilon Fc receptor
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumNorwayDenmark +[4] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGenentech Inc
China Registration ClassN/A

Develop Information

Active CompaniesGenentech Inc
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A